Our Website Uses Cookies
We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.
For more information, please contact us or consult our Privacy Notice.
Your binder contains too many pages, the maximum is 40.
We are unable to add this page to your binder, please try again later.
This page has been added to your binder.
Regulation of Products for Animals - Part II
January 13, 2010, FDLI/FDA Commissioner’s Fellowship Program
October 7, 2014
LONDON, 7 October, 2014 — Covington & Burling advised Horizon Discovery Group plc, an AIM listed international life science company supplying research tools and services to organizations engaged in genomics research and the development of personalized medicines, on the acquisition of Sage Labs Inc. for a total of approximately $48 million (£29 million), ...
December 11, 2012
LONDON, 11 December, 2012 — Covington & Burling acted as legal advisers to Meda in its acquisition of MidNite, an OTC sleep-aid product. Meda is a leading international specialty pharmaceutical company. The Covington team was led by partner Peter Laveran with assistance from Karen Brooks. The team also included Philip Young and trainee Philippe Bradley ...
Covington Advises Coty on Deal with Church & Dwight
7/9/2008
NEW YORK, NY, July 9, 2008 — Coty Inc. has completed its previously announced sale of the Orajel brand and other brands of Del Pharmaceuticals to Church & Dwight Co., Inc. for $380 million in cash. Covington & Burling LLP advised Coty on the transaction. Coty is the world’s largest fragrance company with annual sales in excess of $3.5 billion. Church & Dwight ...